Investors & Media

Webcast ImageWebcast
Q1 2016 Ionis Pharmaceuticals Inc Earnings Conference Call (Live)
05/04/16 at 10:30 a.m. ET
Q1 2016 Ionis Pharmaceuticals Inc Earnings Conference Call
Wednesday, May 4, 2016 10:30 a.m. ET  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
41st Annual Deutsche Bank Health Care Conference (Live)
05/05/16 at 12:00 p.m. ET
41st Annual Deutsche Bank Health Care Conference
Thursday, May 5, 2016  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Webcast ImageWebcast
Ionis Annual Stockholder Meeting and Open House (Live)
06/03/16 at 2:00 p.m. PT
Ionis Annual Stockholder Meeting and Open House
Friday, June 3, 2016 2:00 p.m. PT  
Webcast PresentationHelp Help
Click here for webcast
Add to CalendarHelp Help
Add to Calendar Click here to add this event to your calendar
Company Profile
We are the leading company in RNA-targeted drug discovery and development with a pipeline of first-in-class or best-in-class medicines with the potential to provide high value for patients with significant unmet medical needs. We have created an efficient and broadly applicable drug discovery platform. Using this platform, we believe that we are revolutionizing medicine with the goal to improve the quality of, and save, lives.
Recent Press ReleasesMore >>
DateTitle 
04/22/16Webcast Alert: Ionis Pharmaceuticals' First Quarter 2016 Financial Results Conference Call
- Webcast scheduled for Wednesday, May 4 at 10:30 a.m. Eastern Time CARLSBAD, Calif., April 22, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that it will host a live webcast on Wednesday, May 4 at 10:30 a.m. Eastern Time to discuss its first quarter 2016 financial results, and report on pipeline and business progress. Interested parties may listen to the call by dialing 877-443-5662 or access the webcast at www.ionispharma.com. A webcast replay will be ... 
Printer Friendly Version
04/20/16Ionis Pharmaceuticals Reports Data Update from Nusinersen Phase 2 Study in Infants with Spinal Muscular Atrophy and Reviews Neurological Disease Franchise
Webcast scheduled for Thursday, April 21 at 11:00 a.m. PDT/ 2:00 p.m. EDT CARLSBAD, Calif., April 20, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today provided an update on its ongoing open-label Phase 2 clinical study of nusinersen in infants with spinal muscular atrophy (SMA) at the American Academy of Neurology (AAN) meeting in Vancouver, BC.  The data reported today show that there have been no new events, as defined by progression to permanent ventilation or death, i... 
Printer Friendly Version
04/15/16Ionis Pharmaceuticals Highlights Antisense Drugs to Treat Neurological Diseases at the AAN Meeting
Ionis and its collaborators to present more than 12 presentations and posters on Ionis' neurological disease programs Webcast to provide update on nusinersen Phase 2 open-label study in infants with SMA and to review Ionis' other neurological disease programs scheduled for Thursday, April 21 at 2:00 p.m. EDT CARLSBAD, Calif., April 15, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) announced today that Ionis and its collaborators will present a dozen presentations and post... 
Printer Friendly Version
04/07/16Ionis Pharmaceuticals Provides Update on IONIS-TTRRX Program
CARLSBAD, Calif., April 7, 2016 /PRNewswire/ -- Ionis Pharmaceuticals, Inc. (NASDAQ: IONS) today provided an update on the IONIS-TTRRx program. IONIS-TTRRx is currently being evaluated by IONIS in an ongoing Phase 3 study, NEURO-TTR, in patients with transthyretin (TTR) familial amyloid polyneuropathy. A Phase 3 study, CARDIO-TTR, is also being planned by GSK to evaluate IONIS-TTRRx in patients with TTR amyloid cardiomyopathy.  GSK is in the process of finalizing the protocol for the CARDI... 
Printer Friendly Version
Upcoming EventsMore >>
DateTitle
05/04/16 10:30 a.m. ET
Q1 2016 Ionis Pharmaceuticals Inc Earnings Conference Call
05/05/16
41st Annual Deutsche Bank Health Care Conference
06/03/16 2:00 p.m. PT
Ionis Annual Stockholder Meeting and Open House
06/08/16
Goldman Sachs 37th Annual Global Healthcare Conference
07/13/16 8:00 a.m. ET
Ionis R&D Day

For more information requests, please visit our Information Request page.

If you are interested in Ionis Pharmaceuticals’ investment details,
please visit our Investor FAQ page.

Data provided by Nasdaq. Minimum 15 minutes delayed.